Cargando…

AKR7A3 suppresses tumorigenicity and chemoresistance in hepatocellular carcinoma through attenuation of ERK, c-Jun and NF-κB signaling pathways

Hepatocellular carcinoma (HCC), which accounts for 85–90% of primary liver cancer, is now the second leading cause of cancer-related mortality worldwide. Here we reported that Aldo-Keto Reductase family 7A isoform 3 (AKR7A3) is frequently down-regulated in HCC, associating with poor overall survival...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chow, Raymond Kwok Kei, Tsz-Kwan Sin, Sarah, Liu, Ming, Li, Yan, Man Chan, Tim Hon, Song, Yangyang, Chen, Leilei, Lai-Wan Kwong, Dora, Guan, Xin-Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663529/ https://www.ncbi.nlm.nih.gov/pubmed/29137357 http://dx.doi.org/10.18632/oncotarget.12726

Ejemplares similares

Ruthenium complexes show potent inhibition of AKR1C1, AKR1C2, and AKR1C3 enzymes and anti-proliferative action against chemoresistant ovarian cancer cell line
por: Kljun, Jakob, et al.
Publicado: (2022)

Chemoresistance in H-Ferritin Silenced Cells: The Role of NF-κB
por: Aversa, Ilenia, et al.
Publicado: (2018)

NF-κB is a Critical Mediator of BRCA1 induced Chemoresistance
por: Harte, Mary T, et al.
Publicado: (2013)

EV-Mediated Chemoresistance in the Tumor Microenvironment: Is NF-κB a Player?
por: Di Vito Nolfi, Mauro, et al.
Publicado: (2022)

AKR1B10 confers resistance to radiotherapy via FFA/TLR4/NF-κB axis in nasopharyngeal carcinoma
por: Liu, Xiangting, et al.
Publicado: (2021)

PPFIBP1 activates NF-κB signaling to enhance chemoresistance of multiple myeloma
por: Deng, Yi, et al.
Publicado: (2023)

Cytogenetic Evolution of Human Ovarian Cell Lines Associated with Chemoresistance and Loss of Tumorigenicity
por: Struski, Stéphanie, et al.
Publicado: (2003)

Jagged-2 (JAG2) enhances tumorigenicity and chemoresistance of colorectal cancer cells
por: Vaish, Vivek, et al.
Publicado: (2017)

C-Jun Activation-Dependent Tumorigenic Transformation Induced Paradoxically by Overexpression or Block of S-Adenosylmethionine Decarboxylase
por: Paasinen-Sohns, Aino, et al.
Publicado: (2000)

Enzymes of the AKR1B and AKR1C Subfamilies and Uterine Diseases
por: Rižner, Tea Lanišnik
Publicado: (2012)

Cyclo-Oxygenase 2 Modulates Chemoresistance in Breast Cancer Cells Involving NF-κB
por: Zatelli, Maria Chiara, et al.
Publicado: (2009)

Autophagy inhibition reduces chemoresistance and tumorigenic potential of human ovarian cancer stem cells
por: Pagotto, Anna, et al.
Publicado: (2017)

AKR1B10 promotes breast cancer cell migration and invasion via activation of ERK signaling
por: Li, Jia, et al.
Publicado: (2017)

CUEDC2 suppresses glioma tumorigenicity by inhibiting the activation of STAT3 and NF-κB signaling pathway
por: Li, Feng, et al.
Publicado: (2017)

Inactivation of TFEB and NF-κB by marchantin M alleviates the chemotherapy-driven pro-tumorigenic senescent secretion
por: Niu, Huanmin, et al.
Publicado: (2019)

Reciprocal Role of ERK and Nf-κb Pathways in Survival and Activation of Osteoclasts
por: Miyazaki, Tsuyoshi, et al.
Publicado: (2000)

AKR1B10 promotes breast cancer cell proliferation and migration via the PI3K/AKT/NF-κB signaling pathway
por: Qu, Jiayao, et al.
Publicado: (2021)

Pseudogene AKR1B10P1 enhances tumorigenicity and regulates epithelial‐mesenchymal transition in hepatocellular carcinoma via stabilizing SOX4
por: Hao, Fengjie, et al.
Publicado: (2020)

MGL1 Receptor Plays a Key Role in the Control of T. cruzi Infection by Increasing Macrophage Activation through Modulation of ERK1/2, c-Jun, NF-κB and NLRP3 Pathways
por: Rodriguez, Tonathiu, et al.
Publicado: (2020)

Acetylation of KLF5 maintains EMT and tumorigenicity to cause chemoresistant bone metastasis in prostate cancer
por: Zhang, Baotong, et al.
Publicado: (2021)

CBX7 suppresses urinary bladder cancer progression via modulating AKR1B10–ERK signaling
por: Huang, Zhengnan, et al.
Publicado: (2021)

Expression of the Aldo-Ketoreductases AKR1B1 and AKR1B10 in Human Cancers
por: Laffin, Brian, et al.
Publicado: (2012)

Diagnostic and prognostic values of AKR1C3 and AKR1D1 in hepatocellular carcinoma
por: Zhu, Pengfei, et al.
Publicado: (2021)

AKR1B1 and AKR1B10 as Prognostic Biomarkers of Endometrioid Endometrial Carcinomas
por: Hojnik, Marko, et al.
Publicado: (2021)

Curcumin Inhibits ERK/c-Jun Expressions and Phosphorylation against Endometrial Carcinoma
por: Zhang, Zhenxue, et al.
Publicado: (2019)

Interleukin 26 Skews Macrophage Polarization Towards M1 Phenotype by Activating cJUN and the NF-κB Pathway
por: Lin, Yi-Hsuan, et al.
Publicado: (2020)

The Expressions of NF−κB, COX−2, Sp1, and c−Jun in Pancreatic Ductal Adenocarcinoma and Their Associations with Patient Survival
por: Renaldi, Kaka, et al.
Publicado: (2023)

ERK-mediated NF-κB activation through ASIC1 in response to acidosis
por: Chen, B, et al.
Publicado: (2016)

NF-κB-HOTAIR axis links DNA damage response, chemoresistance and cellular senescence in ovarian cancer
por: Özeş, Ali R., et al.
Publicado: (2016)

Genetic study of lymphoma induction by AKR mink cell focus-inducing virus in AKR x NFS crosses
Publicado: (1981)

AEG-1 Promotes Metastasis Through Downstream AKR1C2 and NF1 in Liver Cancer
por: Li, Cong, et al.
Publicado: (2015)

Sox2 enhances the tumorigenicity and chemoresistance of cancer stem-like cells derived from gastric cancer
por: Tian, Tian, et al.
Publicado: (2012)

An NF-κB–Dependent Role for JunB in the Induction of Proinflammatory Cytokines in LPS-Activated Bone Marrow–Derived Dendritic Cells
por: Gomard, Tiphanie, et al.
Publicado: (2010)

Resveratrol suppresses hyperglycemia-induced activation of NF-κB and AP-1 via c-Jun and RelA gene regulation
por: Mohammadpou, Zinat, et al.
Publicado: (2018)

miR-1266 Contributes to Pancreatic Cancer Progression and Chemoresistance by the STAT3 and NF-κB Signaling Pathways
por: Zhang, Xin, et al.
Publicado: (2018)

Rab27A overexpression promotes bladder cancer proliferation and chemoresistance through regulation of NF-κB signaling
por: Liu, Jia, et al.
Publicado: (2017)

TRIM32 promotes proliferation and confers chemoresistance to breast cancer cells through activation of the NF-κB pathway
por: Zhao, Ting-Ting, et al.
Publicado: (2018)

Rsf-1 regulates malignant melanoma cell viability and chemoresistance via NF-κB/Bcl-2 signaling
por: He, Jiani, et al.
Publicado: (2019)

Leptin Inhibits Neutrophil Apoptosis in Children via ERK/NF-κB-Dependent Pathways
por: Sun, Zhizhi, et al.
Publicado: (2013)

The ERK5/NF-κB signaling pathway targets endometrial cancer proliferation and survival
por: Diéguez-Martínez, Nora, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_srmsb7vg55fij7vtq5sc2hd2eg